Tanya Barauskas Dorff, M.D., is professor of medicine in the Department of Medical Oncology & Therapeutics Research and serves as Section Chief of the Genitourinary cancers program at City of Hope.

She has published over 100 original research manuscripts along with more than 50 review articles and editorials, in addition to serving on the NCCN Prostate Cancer Guidelines panel and co-chair of Prostate Cancer for SWOG. Her research interests in prostate cancer are focused on novel immunotherapy and combination strategies. With the support of the Prostate Cancer Foundation she is leading a trial of a novel PSCA targeted chimeric antigen receptor (CAR) T cell developed by Dr. Priceman at City of Hope, and has federal and foundation funding for projects studying early PARP inhibition in diverse prostate cancer patients and ctDNA as a tool in understanding cancer evolution.